Monday, October 26, 2026 · Daily editionET --:--:--

Finished

PURO - PUlmonary Rehabilitation With O-RAGT Platform

NCT05757830 · Fondazione Don Carlo Gnocchi ETS · Updated 15 June 2023

What is being tested
UANGO suite exoskeleton
For
Multiple Sclerosis; Spinal Cord Injury; Stroke; Traumatic Brain Damage
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 90 years. About 20 people. The full rules are on the registry page.
Where
Italy, Lithuania, Netherlands, Spain (4 sites)
When
Starts or started 23 Dec 2022, ends 31 March 2023. Registered 7 March 2023.
Results
None posted yet.

In the researchers' words

The goal of this interventional study is to assess differences in the metabolic consumption, the cardiorespiratory effort, the cardiac autonomic adaptation, and fatigability during ADL, such as standing from a chair and walking while wearing an electrically powered exoskeleton in different modes of supports in subjects with neurological diseases with moderate to severe walking impairments.
ClinicalTrials.gov, NCT05757830

Sites

  • Fondazione Don Carlo GnocchiMilan, MI, Italy
  • Lithuanian University of Health SciencesKaunas, Lithuania
  • Roessingh Research and DevelopmentEnschede, AH, Netherlands
  • Hospital Nacional de Parapléjicos de ToledoToledo, Spain